| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Ferric maltol |
| Brand | Feraccru® |
| Indication | For the treatment of iron deficiency anaemia (IDA) in inflammatory bowel disease (IBD) in adult patients. |
| Assessment Process | |
| Full pharmacoeconomic assessment commissioned by HSE | 12/08/2016 |
| NCPE assessment completed | 06/09/2016 |
| NCPE assessment outcome | Reimbursement not recommended. |